We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Medtronic has announced results of the COMPASS-HF (Chronicle Offers Management
to Patients with Advanced Signs and Symptoms of Heart Failure) clinical trial
that were presented at the American College of Cardiology Annual Scientific
Session.
IDev Technologies has received 510(k) clearance from the FDA to market the AKonya
Eliminator Plus Mechanical Thrombectomy Device in the U.S. and has commercially
released the CE-Marked device into the European market, the company said.
Dade Behring, a maker of blood-testing kits, has received FDA approval to use
its NT-proBNP test on the company's Stratus CS Acute Care Diagnostics System.
MIV Therapeutics (MIVT) , a developer of next-generation drug-eluting coatings
that inhibit the rejection of implanted medical devices, has announced the successful
completion of pilot preclinical studies of hydroxyapatite (HAp) coated stents
in pig coronary arteries.
Vascular Solutions has received notification from the Japanese Ministry of Health,
Labor and Welfare of regulatory approval for the Pronto extraction catheter.
Boston Scientific has completed its acquisition of Advanced Stent Technologies
(AST) of Pleasanton, Calif., for an initial payment of $120 million payable
in Boston Scientific stock, plus the possibility of future contingent payments.
ReGen Biologics, an orthopedic products company that develops, manufactures
and markets innovative products for human tissue repair in the U.S. and abroad,
has announced that the company has regained its rights to exclusively market
and distribute its patented Collagen Meniscus Implant throughout the world.
Biotechnology company Chiron said that it settled a suit against a licenser
of cystic fibrosis products that will require the company, SourceCF, to attach
a warning label on promotional materials for an electronic inhaler.